Tiziana Life Sciences Ltd

DB:0RP Stock Report

Market Cap: €105.1m

Tiziana Life Sciences Past Earnings Performance

Past criteria checks 0/6

Tiziana Life Sciences's earnings have been declining at an average annual rate of -4.3%, while the Biotechs industry saw earnings growing at 7.7% annually.

Key information

-4.3%

Earnings growth rate

-2.8%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth raten/a
Return on equity-740.1%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Tiziana Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0RP Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-1487
31 Mar 240-1698
31 Dec 230-18108
30 Sep 230-19108
30 Jun 230-20109
31 Mar 230-17611
31 Dec 220-15213
30 Sep 220-13114
30 Jun 220-11015
31 Mar 220-17714
31 Dec 210-231413
30 Sep 210-312312
30 Jun 210-383111
31 Mar 210-32288
31 Dec 200-26246
30 Sep 200-18164
30 Jun 200-1073
31 Mar 200-1073
31 Dec 190-964
30 Sep 190-864
30 Jun 190-855
31 Mar 190-855
31 Dec 180-846
30 Sep 180-846
30 Jun 180-956
31 Mar 180-956
31 Dec 170-946
30 Sep 170-1156
30 Jun 170-1266
31 Mar 170-1055
31 Dec 160-954
30 Sep 160-945
30 Jun 160-936
31 Mar 160-1148
31 Dec 150-1339
30 Sep 150-1147
30 Jun 150-945
31 Mar 150-733

Quality Earnings: 0RP is currently unprofitable.

Growing Profit Margin: 0RP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0RP is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.

Accelerating Growth: Unable to compare 0RP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0RP is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: 0RP has a negative Return on Equity (-740.05%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies